Milestone Pharmaceuticals Inc.

Healthcare · Biotechnology · Canada

Last price 0.73 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 102.86M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Ph...